Why Are Asthma & COPD the #1 Cause of Preventable ED Visits?

By Dr. Jennifer Chambers, MD

Asthma and Chronic Obstructive Pulmonary Disease (COPD) are chronic respiratory conditions characterized by symptoms like cough, wheezing, chest tightness, and shortness of breath, significantly impacting quality of life. These conditions often coexist with comorbidities such as cardiovascular diseases, diabetes, and anxiety/depression.

Repeated exacerbations of asthma and COPD create a vicious cycle. These exacerbations, marked by debilitating shortness of breath, reduce physical activity, negatively affecting cardiovascular health and insulin resistance. Steroid treatments for exacerbations, like prednisone, can further impact the body by affecting appetite, blood sugar, blood pressure, and mood, worsening preexisting conditions like diabetes, hypertension, obesity, and anxiety/depression.  Lets explore the vicious cycle further.

Understanding Exacerbations

Exacerbations are episodes where asthma or COPD symptoms suddenly worsen, often requiring emergency treatment. Triggers include infections, allergens, pollution, or other stressors, leading to increased airway inflammation and symptoms like shortness of breath, coughing, and wheezing.

Impact on Comorbidities

  1. Systemic Inflammation: Persistent systemic inflammation from repeated exacerbations can worsen cardiovascular conditions like heart failure and ischemic heart disease, and exacerbate diabetes by affecting insulin sensitivity and glucose metabolism.

  2. Increased Medication Use: Managing exacerbations often involves corticosteroids, which can lead to side effects like osteoporosis, hypertension, and increased blood sugar levels, complicating diabetes and cardiovascular diseases.

  3. Physical Inactivity: Frequent exacerbations reduce physical activity due to breathlessness and fatigue. This inactivity is a risk factor for comorbidities like obesity, cardiovascular diseases, and depression, and can lead to muscle wasting and decreased fitness.

  4. Psychological Stress: The stress and anxiety from frequent exacerbations can worsen mental health conditions like depression and anxiety, negatively impacting the management of other chronic conditions.

  5. Healthcare Utilization: Repeated exacerbations increase healthcare utilization, including hospitalizations and emergency visits, leading to higher healthcare costs and financial stress, indirectly affecting the management of comorbid conditions.

To break the vicious cycle of exacerbations in asthma and COPD, a comprehensive management approach is essential:

  • Regular Monitoring: Detect early signs/symptoms of exacerbations to prevent worsening through early intervention.

  • Personalized Treatment Plans: Address respiratory conditions, social needs, and self-management education.

  • Lifestyle Modifications: Provide wellness coaching to encourage physical activity, a healthy diet, and smoking cessation.

  • Mental Health Support: Provide psychological support and counseling given the high risk of depression and anxiety experienced by folks living with chronic lung disease.

The Nightingale Virtual Respiratory Care Program embodies these principles. It uses a whole-person approach with a discreet wearable device that collects data on symptoms, biometrics, and activity. Supported by respiratory therapists and self-management education, this program identifies symptom changes early, allowing timely interventions to prevent exacerbations.

Preventing exacerbations reduces healthcare costs and improves the management of comorbidities affected by systemic inflammation and steroid use. By understanding and addressing the mechanisms behind exacerbations, programs like Nightingale can enhance the quality of life for patients with asthma and COPD and decrease healthcare costs related to preventable exacerbations.

A combination of virtual and asynchronous care pathways to improve health outcomes and reduce avoidable hospital visits.

Respiratory Symptom Reductions Measured Using the Gold-Standard SGRQ Methodology & Validated by Independent Third Party Guarantee

Members experience significantly fewer sleep disturbances due to respiratory symptoms at 6 and 12 months.

Members experience significantly fewer respiratory symptoms during physical activity at 6 and 12 months.

Members experience significantly fewer Asthma attacks and COPD flare-ups at 6 and 12 months, with 77% reporting no attacks.

  • Comprehensive Asthma Management: Nightingale offers personalized care through virtual and asynchronous pathways, ensuring tailored support for each child.
  • Advanced Monitoring Technology: ADAMM, a proprietary wearable device, tracks respiratory symptoms in real-time, providing insights to caregivers and clinicians.
  • Specialized Respiratory Team: Access to a network of pediatric respiratory therapists, pulmonologists, wellness coaches, and behavioral health specialists.
  • Proven Cost Savings: Reduces avoidable hospital visits and lowers overall healthcare costs through effective asthma management.
  • Turnkey Solution for Plans: Easy integration with Medicaid Managed Care plans with customizable options and minimal operational burden.

The #1 Clinically Validated Respiratory Care Solution

77%

of members with Asthma or COPD report zero attacks after 6 months.

65%

of members are still engaged with the program at 1 year

10 years of clinical validation makes the program a market leader